For some Chinese corporates, a delayed UPC agreement might be a welcome development

IAM’s Hong Kong-based editorial team recently visited the headquarters of a Chinese company in the med-tech sector. As we stood before a wall decorated on the left half with framed USPTO patent certificates and on the right half with framed SIPO…

Get unlimited access to all IAM content